Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis

被引：16

作者：

John, S ^{[1
]}

Smith, S

Morrison, JF

Symmons, D

Worthington, J

Silman, A

Barton, A

机构：

[1] Univ Manchester, Manchester, Lancs, England

[2] AstraZeneca Pharmaceut Ltd, Macclesfield, Cheshire, England

来源：

ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 12期

关键词：

D O I：

10.1002/art.11360

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3615 / 3616

页数：2

共 14 条

[1]

ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315

[2]

Brennan P, 1996, BRIT MED J, V313, P471

[3] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].

COCCHI, F ;

DEVICO, AL ;

GARZINODEMO, A ;

ARYA, SK ;

GALLO, RC ;

LUSSO, P .

SCIENCE, 1995, 270 (5243) :1811-1815

[4]

Cooke SP, 1998, ARTHRITIS RHEUM, V41, P1135, DOI 10.1002/1529-0131(199806)41:6<1135::AID-ART24>3.0.CO

[5]

2-N

[6] EVALUATION OF THE 1987 REVISED CRITERIA FOR RHEUMATOID-ARTHRITIS IN A COHORT OF NEWLY DIAGNOSED FEMALE-PATIENTS [J].

DUGOWSON, CE ;

NELSON, JL ;

KOEPSELL, TD .

ARTHRITIS AND RHEUMATISM, 1990, 33 (07) :1042-1046

[7] MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].

FRIES, JF ;

SPITZ, P ;

KRAINES, RG ;

HOLMAN, HR .

ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145

[8]

Garred P, 1998, J RHEUMATOL, V25, P1462

[9]

Gómez-Reino JJ, 1999, ARTHRITIS RHEUM-US, V42, P989, DOI 10.1002/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO

[10]

2-U

← 1 2 →